| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 103300-74-9 | 他替瑞林; (4S)-N-[(2S)-1-[(2S)-2-氨基甲酰基吡咯烷-1-基]-3-(3H-咪唑-4-基)-1-氧代丙-2-基]-1-甲基-2,6-二 | Taltirelin; (4S)-N-[(2S)-1-[(2S)-2-Carbamoylpyrrolidin-1-yl]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide |  | C17H23N7O5 | 詳情 | 供應(yīng)商 |
| 144143-96-4 | 甲磺酸依普羅沙坦; 4-[[2-丁基-5-(2-甲�；�-3-噻吩-2-基-丙烯-1-基)-咪唑-1-基]甲基]苯甲酸甲磺酸鹽 | Eprosartan mesylate; 4-[[2-Butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)-imidazol-1-yl]methyl]benzoic acid mesylate |  | C24H28N2O7S2 | 詳情 | 供應(yīng)商 |
| 168626-94-6 | N-[4-(2-甲基-4,5-二氫-3H-咪唑并[4,5-D][1]苯并氮雜卓-6-甲�；�)苯基]-2-苯基苯甲酰胺鹽酸鹽 | Conivaptan hydrochloride; Conivaptan hydrochloride; N-[4-(2-Methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide hydrochloride; (1,1'-Biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride; Conivaptan HCl; Conivaptan hydrochloride [usan]; Unii-75L57R6X36; Vaprisol |  | C32H27ClN4O2 | 詳情 | 供應(yīng)商 |
| 140174-48-7 | 4-甲酰基-N,N-二甲基-1H-咪唑-1-磺酰胺 | N,N-Dimethyl 4-formyl-1H-imidazole-1-sulfonamide; 4-Formyl-N,N-dimethyl-1H-imidazole-1-sulfonamide; N,N-Dimethyl 4-formyl-1H-imidazole-1-sulfonamide |  | C6H9N3O3S | 詳情 | 供應(yīng)商 |
| 875337-44-3 | N-(3-氟-4-(2-(1-甲基-1H-咪唑-4-基)噻吩并[3,2-B]吡啶-7-氧基)苯基氨基硫代甲酰基)-2-苯乙酰胺; N-(3-氟-4- | N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phen; N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide; MGCD-265 (Synonyms MGCD265); MGCD-265 |  | C26H20FN5O2S2 | 詳情 | 供應(yīng)商 |